PGF2α dimethyl amine is a derivative of PGF2α which was designed as a PG antagonist for in vitro and in vivo studies. PGF2α dimethyl amine is a weak FP receptor antagonist. In gerbil colon, PGF2α dimethyl amine at a dose of 3.2 μg/ml inhibits the contractile effects of PGF2α (at 6 ng/ml) by 60%.
